Pooja Toshniwal Paharia

Pooja Toshniwal Paharia

M.D.S (OMR) - Masters in Dental Surgery (Oral Medicine and Radiology)

Oral Medicine, Radiology

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders. Her expertise involves diagnosing and managing potentially malignant as well as malignant lesions and conditions, temporomandibular joint disorders, orofacial pain conditions, salivary gland disorders, developmental anomalies, dental management of systemic conditions and medical emergencies, etc. using conservative treatments inclusive of medications, physiotherapy, biofeedback coupled gold standards such as surgical excisions and advanced techniques such as low-level laser therapy and transcutaneous electric nerve stimulation.

See more

During her post-graduation, she received accolades at several national and international conferences for her scientific research papers and the Academic Excellence Award for two consecutive years at her educational institute. Her field of interest has always been the use of advanced and non-invasive novel diagnostic as well as therapeutic techniques for maxillofacial disorders to provide an improved standard of care to patients. She has worked extensively on several research projects based on molecular spectroscopic analysis of proteins and nucleic acids and radiological assessment of morphological alterations correlated with disease severity in potentially malignant conditions. She has also worked on systematic reviews on the immunological management of Sjogren’s syndrome using novel monoclonal antibodies. As part of her post-graduation curriculum, she has undertaken several scientific writing assignments based on weekly reviews of constantly updated scientific literature published in peer-reviewed medical journals.

She is currently working as a consultant oral and maxillofacial radiologist at an advanced dental diagnostic center in India and provides three-dimensional and accurate radiological diagnostic information to doctors and patients on several dental conditions. Pooja is passionate about writing and dental health. Outside of work, she enjoys art, music, traveling, reading, and cooking.

See less

Articles from Pooja Toshniwal Paharia

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Study describes the symptom profiles of the main variants of SARS-CoV-2

Study describes the symptom profiles of the main variants of SARS-CoV-2

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

The effectiveness of molnupiravir and nirmatrelvir/ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients

The effectiveness of molnupiravir and nirmatrelvir/ritonavir in reducing hospitalization and deaths in non-hospitalized COVID-19 patients

The impact of SARS-CoV-2 nucleocapsid protein mutations on the performance of rapid antigen tests

The impact of SARS-CoV-2 nucleocapsid protein mutations on the performance of rapid antigen tests

Hamster contact exposure challenge model assesses protection conferred by SARS-CoV-2 vaccination or prior infection against reinfection

Hamster contact exposure challenge model assesses protection conferred by SARS-CoV-2 vaccination or prior infection against reinfection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.